Clinical Scorecard: Mobile Application-Based Assessment for Predicting Dopaminergic Deficiency in Early and Established Parkinson’s Disease

At a Glance

Key Highlights

• Smartphone-based motor assessments can predict dopamine transporter (DaT) SPECT scan abnormalities with good accuracy (AUC up to 0.85 when combined with clinical scores).
• Gait, tremor, and dexterity features derived from smartphone tests are the most predictive of dopaminergic deficiency.
• Digital assessments offer a scalable, cost-effective alternative to DaT SPECT imaging, which is costly, less accessible, and involves radiation exposure.

Guideline-Based Recommendations

Diagnosis

• Use DaT SPECT imaging to confirm dopaminergic deficiency in Parkinson’s disease and differentiate from mimics.
• Consider smartphone-based motor assessments as complementary tools to clinical evaluation for identifying dopaminergic deficits.

Management

• Employ smartphone-derived motor features alongside MDS-UPDRS-III scores to improve detection of dopaminergic deficiency.
• Utilize digital tools to facilitate early identification and monitoring in prodromal and established Parkinson’s disease.

Monitoring & Follow-up

• Monitor motor symptom progression using standardized clinical scales such as MDS-UPDRS-III and smartphone-based assessments.
• Leverage longitudinal smartphone data to predict clinical transition points including gait freezing and cognitive impairment.

Risks

• DaT SPECT imaging involves ionising radiation and requires specialised equipment, limiting frequent use.
• Smartphone assessments require further large-scale independent validation before widespread clinical adoption.

Patient & Prescribing Data

Individuals with Parkinson’s disease and prodromal iRBD at risk of phenoconversion

Smartphone-based motor testing can aid in identifying dopaminergic deficiency and support targeted recruitment for clinical trials, potentially enabling earlier intervention.

Clinical Best Practices

• Combine smartphone-derived motor features with clinical motor scales (MDS-UPDRS-III) for improved diagnostic accuracy.
• Incorporate digital assessments into routine clinical evaluation to enhance accessibility and reduce reliance on costly imaging.
• Use gait, tremor, and dexterity metrics as key indicators when interpreting smartphone-based motor assessments.
• Recognize the importance of early detection in prodromal stages such as iRBD to enable timely clinical trial enrollment and intervention.

References

• Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)
• Oxford Parkinson’s Disease Centre smartphone application study
• Parkinson’s At Risk Study (PARS)